Premaitha to Launch First CE IVD Noninvasive Prenatal Test in Europe in Early 2015 | GenomeWeb

NEW YORK (GenomeWeb) − As a number of companies have started offering next-generation sequencing-based non-invasive prenatal testing services in Europe, Premaitha Health, a UK-based startup, is pursuing a different strategy: offering a CE-marked in vitro diagnostics NIPT product to local clinical laboratories that already offer other prenatal screening tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.